Save the Date!
The home of Phase 1 in oncology
The ESMO Targeted Anticancer Therapies Congress 2022, known as “The Home of Phase I in Oncology” will offer participants a glimpse of the future of targeted anticancer therapies.
This year's congress will take place as an onsite event, on 7-9 March 2022 in Paris, France, while also providing online access.
TAT is the premier international meeting focusing on promising new anticancer targets and agents, with a particular focus on those in early phase clinical development.
Stakeholders from academy and industry will discuss with clinicians, researchers and regulators the global dissemination of knowledge and clinical research expertise in the field of innovative cancer therapeutics, to the benefit of cancer patients worldwide.
Ruth Plummer, Newcastle-upon-Tyne, UK
Lillian Siu, Toronto, ON, Canada
ESMO Head Office
Via Ginevra 4, 6900 Lugano